Document:

THE
          REGISTERED HOLDER OF THIS REPRESENTATIVES' UNIT PURCHASE OPTION BY ITS
          ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS
          REPRESENTATIVES' UNIT PURCHASE OPTION EXCEPT AS HEREIN PROVIDED AND THE
          REGISTERED HOLDER OF THIS REPRESENTATIVES' UNIT PURCHASE OPTION AGREES
          THAT IT
          WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS REPRESENTATIVES'
          UNIT PURCHASE OPTION FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING
          THE
          EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER THAN (i) I-BANKERS SECURITIES
          INCORPORATED OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH
          THE
          OFFERING; OR (ii) A BONA FIDE OFFICER OR PARTNER OF I-BANKERS OR OF ANY
          SUCH
          UNDERWRITER OR SELECTED DEALER. 

    

    

    THIS
      REPRESENTATIVES' UNIT PURCHASE OPTION IS NOT EXERCISABLE PRIOR TO THE LATER
      OF
      THE CONSUMMATION BY MIDDLE KINGDOM ALLIANCE CORP. (THE “COMPANY”) OF A MERGER,
      CAPITAL STOCK EXCHANGE, ASSET ACQUISITION OR OTHER SIMILAR BUSINESS COMBINATION
      (THE “BUSINESS COMBINATION”) (AS DESCRIBED MORE FULLY IN THE COMPANY’S
      REGISTRATION STATEMENT FILED ON FORM S-1 (No. 333-133475).

    

    THIS
      REPRESENTATIVES' UNIT PURCHASE OPTION IS VOID AFTER 5:00 P.M. EASTERN TIME,
      _______________ 2011. 

    

    

    REPRESENTATIVES'
      UNIT PURCHASE OPTION

    

    FOR
      THE PURCHASE OF 1 UNIT 

    

    OF

    

    MIDDLE
      KINGDOM ALLIANCE CORP. 

    

    THIS
      CERTIFIES THAT, in consideration of $100 duly paid by or on behalf of
      _________________ (“Holder”), as registered owner of this Representatives' Unit
      Purchase Option (the "Representatives' Unit Purchase Option") to Middle Kingdom
      Alliance Corp. (the “Company”), Holder is entitled, at any time or from time to
      time upon the later of the consummation of a Business Combination or
      _____________, 2007 (the “Commencement Date”), and at or before 5:00 p.m.,
      Eastern Time,_____________, 2011 (the “Expiration Date”), but not thereafter, to
      subscribe for, purchase and receive, in whole or in part, one (1) unit (the
      “Representatives' Unit”) of the Company. 

    

    
      	
              1)

            	
              REPRESENTATIVES'
                UNIT PURCHASE OPTION 

            

    

    

      a) The
        Representatives' Unit consists of up to a total of 18,000 Series A Units
        at a
        per-unit price of $10.00 and/or up to a total of 300,000 Series B Units at
        a
        per-unit price of $10.00. The Series A Units and Series B Units that would
        be
        issued upon the exercise of this Representatives’ Purchase Option are identical
        to the Units offered by the Company to the public as set forth in the Prospectus
        and Registration Statement filed with the Securities and Exchange Commission
        (the “Commission”) on Form S-1 (No. 333-133475) as amended, on April 21, 2006.

    

      b) This
        Representatives’ Purchase Option shall be exercisable, in whole or in part,
        commencing on the date the Registration Statement becomes effective (the
        “Effective Date”) and expiring on the five-year anniversary of the Effective
        Date at an initial exercise price per Representatives’ Unit of $10.00, which is
        equal to one hundred twenty-five percent (125%) of the initial public offering
        price of a Firm Unit.

    

      c) The
        Representatives’ Class A and Class B Warrants will be identical to those offered
        to the public except that the Representatives' Class A and Class B Warrants
        shall have an exercise price of $10.00, which is equal to one hundred
        twenty-five percent (125%) of the exercise price of the warrants included
        in the
        Units offered to the public. The Class A and Class B Warrants may be exercised
        during the period commencing on the later of the completion by the Company
        of a
        business combination, as described more fully in the Registration Statement
        (“Business Combination”) or one year from the Effective Date and
        terminating on the seven-year anniversary of the Effective Date or earlier
        upon
        redemption (the "Expiration Date").

    

    
      
        
        

      

      
        Page
          1 of 12

        
          

        

      

      
        
        

      

    

    d) If
      the
      Expiration Date is a day on which banking institutions are authorized by law
      to
      close, then this Representatives' Unit Purchase Option may be exercised on
      the
      next succeeding day which is not such a day in accordance with the terms herein.
      During the period ending on the Expiration Date, the Company agrees not to
      take
      any action that would terminate the Representatives' Unit Purchase Option.
      This
      Representatives' Unit Purchase Option is initially exercisable at $100.00 per
      Unit so purchased; provided, however, that upon the occurrence of any of the
      events specified in Section 6 hereof, the rights granted by this
      Representatives' Unit Purchase Option, including the exercise price per Unit
      and
      the number of Units (and Common Stock, Class B Common Stock and Class A and
      Class B Warrants) to be received upon such exercise, shall be adjusted as
      therein specified. The term “Exercise Price” shall mean the initial exercise
      price or the adjusted exercise price, depending on the context. 

    

    
      	
              2)

            	
              EXERCISE
                OF REPRESENTATIVES' UNIT PURCHASE
                OPTION

            

    

    

    a) Exercise
      Procedure.
      In
      order to exercise this Representatives' Unit Purchase Option, the exercise
      form
      attached hereto must be duly executed and completed and delivered to the
      Company, together with this Representatives' Unit Purchase Option and payment
      of
      the Exercise Price for the Units being purchased payable by wire transfer in
      federal (same day) funds or by certified or bank cashier’s check(s) in New York
      Clearing House funds. If the subscription rights represented hereby shall not
      be
      exercised at or before 5:00 p.m., Eastern time, on the Expiration Date, this
      Representatives' Unit Purchase Option shall become and be void without further
      force or effect, and all rights represented hereby shall cease and expire.
      

    

    b) Legend.
      Each
      certificate for the securities purchased under this Representatives' Unit
      Purchase Option shall bear a legend as follows unless such securities have
      been
      registered under the Securities Act of 1933, as amended (the “Act”):

     

    “The
      securities represented by this certificate have not been registered under the
      Securities Act of 1933, as amended (the “Act”) or applicable state law. The
      securities may not be offered for sale, sold or otherwise transferred except
      pursuant to an effective registration statement under the Act, or pursuant
      to an
      exemption from registration under the Act and applicable state law.”

     

    c) Cashless
      Exercise.
      

    

    i) In
      lieu
      of the payment of the Exercise Price multiplied by the number of Units for
      which
      this Representatives' Unit Purchase Option is exercisable (and in lieu of being
      entitled to receive Common Stock and Warrants) in the manner required by Section
      2(a), the Holder shall have the right (but not the obligation) to convert any
      exercisable but unexercised portion of this Representatives' Unit Purchase
      Option into Units (the “Conversion Right”) as follows: upon exercise of the
      Conversion Right, the Company shall deliver to the Holder (without payment
      by
      the Holder of any of the Exercise Price in cash) that number of Common Stock
      and
      Warrants comprising that number of Units equal to the quotient obtained by
      dividing (x) the “Value” (as defined below) of the portion of the
      Representatives' Unit Purchase Option being converted by (y) the Current Market
      Value (as defined below). The “Value” of the portion of the Representatives'
      Unit Purchase Option being converted shall equal the remainder derived from
      subtracting (a) (i) the Exercise Price multiplied by (ii) the number of Units
      underlying the portion of this Representatives' Unit Purchase Option being
      converted from (b) the Current Market Value of a Unit multiplied by the number
      of Units underlying the portion of the Representatives' Unit Purchase Option
      being converted. 

    

    ii) As
      used
      herein, the term “Current Market Value” per Unit at any date means the remainder
      derived from subtracting (x) the exercise price of the Warrants multiplied
      by
      the number of shares of Common Stock issuable upon exercise of the Warrants
      underlying one Unit from (y) the Current Market Price of the Common Stock
      multiplied by the number of shares of Common Stock underlying the Warrants
      and
      the Common Stock issuable upon exercise of one Unit. The “Current Market Price”
of a share of Common Stock shall mean (i) if the Common Stock is listed on
      a
      national securities exchange or quoted on the Nasdaq National Market, Nasdaq
      SmallCap Market or NASD OTC Bulletin Board (or successor such as the Bulletin
      Board Exchange), the last sale price of the Common Stock in the principal
      trading market for the Common Stock as reported by the exchange, Nasdaq or
      the
      NASD, as the case may be; (ii) if the Common Stock is not listed on a national
      securities exchange or quoted on the Nasdaq National Market, Nasdaq SmallCap
      Market or the NASD OTC Bulletin Board (or successor such as the Bulletin Board
      Exchange), but is traded in the residual over-the-counter market, the closing
      bid price for the Common Stock on the last trading day preceding the date in
      question for which such quotations are reported by the Pink Sheets, LLC or
      similar publisher of such quotations; and (iii) if the fair market value of
      the
      Common Stock cannot be determined pursuant to clause (i) or (ii) above, such
      price as the Board of Directors of the Company shall determine, in good faith.
      

    

    
      
        
        

      

      
        Page
          2 of 12

        
          

        

      

      
        
        

      

    

    iii) The
      Cashless Exercise Right may be exercised by the Holder on any business day
      on or
      after the Commencement Date and not later than the Expiration Date by delivering
      the Representatives' Unit Purchase Option with the duly executed exercise form
      attached hereto with the cashless exercise section completed to the Company,
      exercising the Cashless Exercise Right and specifying the total number of Units
      the Holder will purchase pursuant to such Cashless Exercise Right. 

    

    d) Notwithstanding
      anything to the contrary contained in this Representatives' Unit Purchase
      Option, in no event will the Company be required to net cash settle the exercise
      of the Representatives' Unit Purchase Option or the Warrants underlying the
      Unit
      Purchase Option. The holder of the Representatives' Unit Purchase Option and
      the
      Warrants underlying the Representatives' Unit Purchase Option will not be
      entitled to exercise the Representatives' Unit Purchase Option or the Warrants
      underlying such Unit Purchase Option unless a registration statement is
      effective, or an exemption from the registration requirements is available
      at
      such time and, if the holder is not able to exercise the Representatives' Unit
      Purchase Option or underlying Warrants, the Representatives' Unit Purchase
      Option and/or the underlying Warrants, as applicable, will expire
      worthless

    

    
      	
              3)

            	
              TRANSFER
                

            

    

    

      a)  Restrictions—General.
        The
        registered Holder of this Representatives' Unit Purchase Option, by its
        acceptance hereof, agrees that it will not sell, transfer, assign, pledge
        or
        hypothecate this Representatives' Unit Purchase Option for a period of one
        hundred eighty (180) days following the Effective Date to anyone other than
        (i) I-Bankers Securities Incorporated (“I-Bankers”) or an underwriter or a
        selected dealer in connection with the Offering; or (ii) a bona fide officer
        or
        partner of I-Bankers or of any such underwriter or selected dealer. On and
        after
        the first anniversary of the Effective Date, transfers to others may be made
        subject to compliance with or exemptions from applicable securities laws.
        In
        order to make any permitted assignment, the Holder must deliver to the Company
        the assignment form attached hereto duly executed and completed, together
        with
        the Representatives' Unit Purchase Option and payment of all transfer taxes,
        if
        any, payable in connection therewith. The Company shall within five business
        days transfer this Representatives' Unit Purchase Option on the books of
        the
        Company and shall execute and deliver a new Representatives' Unit Purchase
        Option or Representatives' Unit Purchase Options of like tenor to the
        appropriate assignee(s) expressly evidencing the right to purchase the aggregate
        number of Units purchasable hereunder or such portion of such number as shall
        be
        contemplated by any such assignment. 

    

    b) Restrictions—Securities.
      The
      securities evidenced by this Representatives' Unit Purchase Option shall not
      be
      transferred unless and until (i) the Company has received the opinion of counsel
      for the Holder that the securities may be transferred pursuant to an exemption
      from registration under the Act and applicable state securities laws, the
      availability of which is established to the reasonable satisfaction of the
      Company (the Company hereby agreeing that the opinion of Cozen O'Connor shall
      be
      deemed satisfactory evidence of the availability of an exemption); or (ii)
      a
      registration statement or a post-effective amendment to the Registration
      Statement relating to such securities has been filed by the Company and declared
      effective by the Commission and compliance with applicable state securities
      law
      has been established.

    

    
      	
              4)

            	
              NEW
                PURCHASE OPTIONS TO BE ISSUED

            

    

    

    a) Partial
      Exercise.
      Subject
      to the restrictions in Section 3 hereof, this Representatives' Unit Purchase
      Option may be exercised or assigned in whole or in part. In the event of the
      exercise or assignment hereof in part only, upon surrender of this
      Representatives' Unit Purchase Option for cancellation, together with the duly
      executed exercise or assignment form and funds sufficient to pay any Exercise
      Price and/or transfer tax, the Company shall cause to be delivered to the Holder
      without charge a new Representatives' Unit Purchase Option of like tenor to
      this
      Representatives' Unit Purchase Option in the name of the Holder evidencing
      the
      right of the Holder to purchase the number of Units purchasable hereunder as
      to
      which this Representatives' Unit Purchase Option has not been exercised or
      assigned. 

    

    
      
        
        

      

      
        Page
          3 of 12

        
          

        

      

      
        
        

      

    

    b) Loss,
      Theft, Destruction.
      Upon
      receipt by the Company of evidence satisfactory to it of the loss, theft,
      destruction or mutilation of this Representatives' Unit Purchase Option and
      of
      reasonably satisfactory indemnification or the posting of a bond, the Company
      shall execute and deliver a new Representatives' Unit Purchase Option of like
      tenor and date. Any such new Representatives' Unit Purchase Option executed
      and
      delivered as a result of such loss, theft, mutilation or destruction shall
      constitute a substitute contractual obligation on the part of the Company.
      

    

    
      	
              5)

            	
              REGISTRATION
                RIGHTS

            

    

    

    a) Demand
      Registration.

    

    i) The
      Company, upon written demand (the “Initial Demand Notice”) of the Holder(s) of
      at least 51% of the Representatives' Unit Purchase Options and/or the underlying
      Units and/or the underlying securities (the “Majority Holders”), agrees to
      register on one occasion, all or any portion of the Representatives' Unit
      Purchase Options requested by the Majority Holders in the Initial Demand Notice
      and all of the securities underlying such Representatives' Unit Purchase
      Options, including the Units, Common Stock, the Warrants, and the Common Stock
      underlying the Warrants (collectively, the “Registrable Securities”). On such
      occasion, the Company will file a registration statement or a post-effective
      amendment to the Registration Statement covering the Registrable Securities
      within forty days after receipt of the Initial Demand Notice and use its best
      efforts to have such registration statement or post-effective amendment declared
      effective as soon as possible thereafter. The demand for registration may be
      made at any time during a period of five years beginning on the Effective Date.
      The Company covenants and agrees to give written notice of its receipt of any
      Initial Demand Notice by any Holder(s) to all other registered Holders of the
      Representatives' Unit Purchase Options and/or the Registrable Securities within
      ten days from the date of the receipt of any such Initial Demand Notice.

    

    ii) The
      Company shall bear all fees and expenses attendant to registering the
      Registrable Securities, including the expenses of any legal counsel selected
      by
      the Holders to represent them in connection with the sale of the Registrable
      Securities, but the Holders shall pay any and all underwriting commissions.
      The
      Company agrees to use its reasonable best efforts to qualify or register the
      Registrable Securities in such states as are reasonably requested by the
      Majority Holder(s); provided, however, that in no event shall the Company be
      required to register the Registrable Securities in a state in which such
      registration would cause (i) the Company to be obligated to qualify to do
      business in such state, or would subject the Company to taxation as a foreign
      corporation doing business in such jurisdiction or (ii) the principal
      stockholders of the Company to be obligated to escrow their shares of capital
      stock of the Company. The Company shall cause any registration statement or
      post-effective amendment filed pursuant to the demand rights granted under
      Section 5(a)(i) to remain effective for a period of nine consecutive months
      from
      the effective date of such registration statement or post-effective amendment.
      

    

    b)
      Piggy-Back
      Registration. 

    

    i) In
      addition to the demand right of registration, the Holders of the
      Representatives' Unit Purchase Options shall have the right for a period of
      seven years commencing on the Effective Date, to include the Registrable
      Securities as part of any other registration of securities filed by the Company
      (other than in connection with a transaction contemplated by Rule 145(a)
      promulgated under the Act or pursuant to Form S-8); provided, however, that
      if,
      in the written opinion of the Company’s managing underwriter or underwriters, if
      any, for such offering, the inclusion of the Registrable Securities, when added
      to the securities being registered by the Company or the selling stockholder(s),
      will exceed the maximum amount of the Company’s securities which can be marketed
      (i) at a price reasonably related to their then current market value, and (ii)
      without materially and adversely affecting the entire offering, then the Company
      will still be required to include the Registrable Securities, but may require
      the Holders to agree, in writing, to delay the sale of all or any portion of
      the
      Registrable Securities for a period of 90 days from the effective date of the
      offering, provided, further, that if the sale of any Registrable Securities
      is
      so delayed, then the number of securities to be sold by all stockholders in
      such
      public offering during such 90 day period shall be apportioned pro rata among
      all such selling stockholders, including all holders of the Registrable
      Securities, according to the total amount of securities of the Company owned
      by
      said selling stockholders, including all holders of the Registrable Securities.
      

    

    
      
        
        

      

      
        Page
          4 of 12

        
          

        

      

      
        
        

      

    

    ii) The
      Company shall bear all fees and expenses attendant to registering the
      Registrable Securities, including the expenses of any legal counsel selected
      by
      the Holders to represent them in connection with the sale of the Registrable
      Securities but the Holders shall pay any and all underwriting commissions
      related to the Registrable Securities. In the event of such a proposed
      registration, the Company shall furnish the then Holders of outstanding
      Registrable Securities with not less than fifteen days written notice prior
      to
      the proposed date of filing of such registration statement. Such notice to
      the
      Holders shall continue to be given for each applicable registration statement
      filed (during the period in which the Representatives' Unit Purchase Option
      is
      exercisable) by the Company until such time as all of the Registrable Securities
      have been registered and sold. The holders of the Registrable Securities shall
      exercise the “piggy-back” rights provided for herein by giving written notice,
      within ten days of the receipt of the Company’s notice of its intention to file
      a registration statement. The Company shall cause any registration statement
      filed pursuant to the above “piggyback” rights to remain effective for at least
      nine months from the date that the Holders of the Registrable Securities are
      first given the opportunity to sell all of such securities. 

     

    

    c)
      Indemnification.

    

      i) The
        Company shall indemnify the Holder(s) of the Registrable Securities to be
        sold
        pursuant to any registration statement hereunder and each person, if any,
        who
        controls such Holders within the meaning of Section 15 of the Act or Section
        20(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
        against all loss, claim, damage, expense or liability (including all reasonable
        attorneys’ fees and other expenses reasonably incurred in investigating,
        preparing or defending against litigation, commenced or threatened, or any
        claim
        whatsoever whether arising out of any action between the Underwriter and
        the
        Company or between the Underwriter and any third party or otherwise) to which
        any of them may become subject under the Act, the Exchange Act or otherwise,
        arising from such registration statement but only to the same extent and
        with
        the same effect as the provisions pursuant to which the Company has agreed
        to
        indemnify the Underwriters contained in Section 5 of the Underwriting Agreement
        between the Company, I-Bankers and the other Underwriters named therein
        dated the Effective Date. 

    

    The
      Holder(s) of the Registrable Securities to be sold pursuant to such registration
      statement, and their successors and assigns, shall severally, and not jointly,
      indemnify the Company, its officers and directors and each person, if any,
      who
      controls the Company within the meaning of Section 15 of the Act or Section
      20(a) of the Exchange Act, against all loss, claim, damage, expense or liability
      (including all reasonable attorneys’ fees and other expenses reasonably incurred
      in investigating, preparing or defending against any claim whatsoever) to which
      they may become subject under the Act, the Exchange Act or otherwise, arising
      from information furnished by or on behalf of such Holders, or their successors
      or assigns, in writing, for specific inclusion in such registration statement
      to
      the same extent and with the same effect as the provisions contained in Section
      5 of the Underwriting Agreement pursuant to which the Underwriters have agreed
      to indemnify the Company. 

    

    ii) Nothing
      contained in this Representatives' Unit Purchase Option shall be construed
      as
      requiring the Holder(s) to exercise their Representatives' Unit Purchase Options
      or Warrants underlying such Representatives' Unit Purchase Options prior to
      or
      after the initial filing of any registration statement or the effectiveness
      thereof.

    

    
      
        
        

      

      
        Page
          5 of 12

        
          

        

      

      
        
        

      

    

      iii) The
        Company shall furnish I-Bankers, as Representative of the Holders,
        participating in any of the foregoing offerings, a signed counterpart, addressed
        to the participating Holders, of (i) an opinion of counsel to the Company,
        dated
        the Effective Date of such registration statement (and, if such registration
        includes an underwritten public offering, an opinion dated the date of the
        closing under any underwriting agreement related thereto), and (ii) a “cold
        comfort” letter dated the Effective Date of such registration statement (and, if
        such registration includes an underwritten public offering, a letter dated
        the
        date of the closing under the underwriting agreement) signed by the independent
        public accountants who have issued a report on the Company’s financial
        statements included in such registration statement, in each case covering
        substantially the same matters with respect to such registration statement
        (and
        the prospectus included therein) and, in the case of such accountants’ letter,
        with respect to events subsequent to the date of such financial statements,
        as
        are customarily covered in opinions of issuer’s counsel and in accountants’
letters delivered to underwriters in underwritten public offerings of
        securities. 

    

      The
        Company shall also deliver promptly to I-Bankers, as Representative of the
        Holders participating in the offering, the correspondence and memoranda
        described below and copies of all correspondence between the Commission and
        the
        Company, its counsel or auditors and all memoranda relating to discussions
        with
        the Commission or its staff with respect to the registration statement and
        permit the Representatives to do such investigation, upon reasonable
        advance notice, with respect to information contained in or omitted from
        the
        registration statement as it deems reasonably necessary to comply with
        applicable securities laws or rules of the National Association of Securities
        Dealers, Inc. (the “NASD”). Such investigation shall include access to books,
        records and properties and opportunities to discuss the business of the Company
        with its officers and independent auditors, all to such reasonable extent
        and at
        such reasonable times and as often as I-Bankers, as Representative of the
        Holders, shall reasonably request. The Company shall not be required to disclose
        any confidential information or other records to I-Bankers, as
        Representative of the Holders, or to any other person, until and unless such
        persons shall have entered into reasonable confidentiality agreements (in
        form
        and substance reasonably satisfactory to the Company), with the Company with
        respect thereto.

    

    iv) The
      Company shall enter into an underwriting agreement with the managing
      underwriter(s), if any, selected by any Holders whose Registrable Securities
      are
      being registered pursuant to this Section 5, which managing underwriter shall
      be
      reasonably acceptable to the Company. Such agreement shall be reasonably
      satisfactory in form and substance to the Company, each Holder and such managing
      underwriters, and shall contain such representations, warranties and covenants
      by the Company and such other terms as are customarily contained in agreements
      of that type used by the managing underwriter. The Holders shall be parties
      to
      any underwriting agreement relating to an underwritten sale of their Registrable
      Securities and may, at their option, require that any or all the
      representations, warranties and covenants of the Company to or for the benefit
      of such underwriters shall also be made to and for the benefit of such Holders.
      Such Holders shall not be required to make any representations or warranties
      to
      or agreements with the Company or the underwriters except as they may relate
      to
      such Holders and their intended methods of distribution. Such Holders, however,
      shall agree to such covenants and indemnification and contribution obligations
      for selling stockholders as are customarily contained in agreements of that
      type
      used by the managing underwriter. Further, such Holders shall execute
      appropriate custody agreements and otherwise cooperate fully in the preparation
      of the registration statement and other documents relating to any offering
      in
      which they include securities pursuant to this Section 5. Each Holder shall
      also
      furnish to the Company such information regarding itself, the Registrable
      Securities held by it, and the intended method of disposition of such securities
      as shall be reasonably required to effect the registration of the Registrable
      Securities. 

    

    v) Notwithstanding
      anything contained in this Section 5 to the contrary, the Company shall have
      no
      obligation pursuant to Sections 5(a) or 5(b) for the registration of Registrable
      Securities held by any Holder (i) where such Holder would then be entitled
      to
      sell under Rule 144 within any three-month period (or such other period
      prescribed under Rule 144 as may be provided by amendment thereof) all of the
      Registrable Securities then held by such Holder, and (ii) where the number
      of
      Registrable Securities held by such Holder is within the volume limitations
      under paragraph (e) of Rule 144 (calculated as if such Holder were an affiliate
      within the meaning of Rule 144). 

    

    vi) Each
      Holder agrees, that upon receipt of any written notice from the Company of
      the
      happening of any event as a result of which the prospectus included in the
      Registration Statement, as then in effect, includes an untrue statement of
      a
      material fact or omits to state a material fact required to be stated therein
      or
      necessary to make the statements therein not misleading in light of the
      circumstances then existing, such Holder will immediately discontinue
      disposition of Registrable Securities pursuant to the Registration Statement
      covering such Registrable Securities until such Holder’s receipt of the copies
      of a supplemental or amended prospectus, and, if so desired by the Company,
      such
      Holder shall deliver to the Company (at the expense of the Company) or destroy
      (and deliver to the Company a certificate of such destruction) all copies,
      other
      than permanent file copies then in such Holder’s possession, of the prospectus
      covering such Registrable Securities current at the time of receipt of such
      notice. 

     

    
      
        
        

      

      
        Page
          6 of 12

        
          

        

      

      
        
        

      

    

    
 

    
      	
              6)

            	
              ADJUSTMENTS
                

            

    

    

    a)
      Exercise
      Price and Number of Securities.
      The
      Exercise Price and the number of Units underlying the Representatives' Unit
      Purchase Option shall be subject to adjustment from time to time as hereinafter
      set forth: 

    

      i) If
        after
        the date hereof, and subject to the provisions of Section 6(c) below, the
        number
        of shares of outstanding common stock is increased by a stock dividend payable
        in common stock or by a split-up of common stock or other similar event,
        then,
        on the effective date thereof, the number of shares of common stock underlying
        each of the Units purchasable hereunder shall be increased in proportion
        to such
        increase in outstanding shares. In such case, the number of shares of common
        stock, and the exercise price applicable thereto, underlying the Warrants
        underlying each of the Units purchasable hereunder shall be adjusted in
        accordance with the terms of the Warrants. For example, if prior to a Business
        Combination the Company declares a two-for-one stock dividend and at the
        time of
        such dividend this Representatives' Unit Purchase Option is for the purchase
        of
        one Unit at $100.00 per whole Unit (each Warrant underlying the Units is
        exercisable for $10.00 per share), upon effectiveness of the dividend, this
        Representatives' Unit Purchase Option will be adjusted to allow for the purchase
        of one Unit at $100.00 per Unit, each Unit entitling the holder to receive
        of up
        to a total of 18,000 Series A Units and/or up to a total of 300,000 Series
        B
        Units. For the Series A Units, the Holder shall receive two shares of Common
        Stock and ten Class A Warrants (each Class A Warrant exercisable for $4.40
        per
        share). For the Series B Units, the Holder shall receive two Class B Common
        Shares and two Class B Warrants (each Class B Warrant exercisable for $4.40
        per
        share).

    

    ii) If
      after
      the date hereof, and subject to the provisions of Section 6(c), the number
      of
      outstanding shares of common stock is decreased by a consolidation, combination
      or reclassification of the common stock or other similar event, then, on the
      effective date thereof, the number of shares of common stock underlying each
      of
      the Units purchasable hereunder shall be decreased in proportion to such
      decrease in outstanding shares. In such case, the number of shares of common
      stock, and the exercise price applicable thereto, issuable upon exercise of
      the
      Warrants included in each of the Units purchasable hereunder shall be adjusted
      in accordance with the terms of the Warrants. 

    

    iii) In
      case
      of any reclassification or reorganization of the outstanding common stock other
      than a change covered by Section 6(a)(i) or 6(a)(ii) hereof or that solely
      affects the par value of such common stock, or in the case of any merger or
      consolidation of the Company with or into another corporation (other than a
      consolidation or merger in which the Company is the continuing corporation
      and
      that does not result in any reclassification or reorganization of the
      outstanding common stock), or in the case of any sale or conveyance to another
      corporation or entity of the property of the Company as an entirety or
      substantially as an entirety in connection with which the Company is dissolved,
      the Holder of this Representatives' Unit Purchase Option shall have the right
      thereafter (until the expiration of the right of exercise of this
      Representatives' Unit Purchase Option) to receive upon the exercise hereof,
      for
      the same aggregate Exercise Price payable hereunder immediately prior to such
      event, the kind and amount of shares of stock or other securities or property
      (including cash) receivable upon such reclassification, reorganization, merger
      or consolidation, or upon a dissolution following any such sale or transfer,
      by
      a Holder of the number of Common Stock of the Company obtainable upon exercise
      of this Representatives' Unit Purchase Option and the underlying Warrants
      immediately prior to such event; and if any reclassification also results in
      a
      change in Common Stock covered by Section 6(a)(i) or 6(a)(ii), then such
      adjustment shall be made pursuant to Sections 6(a)(i), 6(a)(ii) and this Section
      6(a)(iii). The provisions of this Section 6(a)(iii) shall similarly apply to
      successive reclassifications, reorganizations, mergers or consolidations, sales
      or other transfers. 

    

    iv) This
      form
      of Representatives' Unit Purchase Option need not be changed because of any
      change pursuant to this Section, and Representatives' Unit Purchase Options
      issued after such change may state the same Exercise Price and the same number
      of Units as are stated in the Representatives' Unit Purchase Options initially
      issued pursuant to this Agreement. The acceptance by any Holder of the issuance
      of new Representatives' Unit Purchase Options reflecting a required or
      permissive change shall not be deemed to waive any rights to an adjustment
      occurring after the Commencement Date or the computation thereof. 

    

    
      
        
        

      

      
        Page
          7 of 12

        
          

        

      

      
        
        

      

    

    b)
      Substitute
      Representatives' Unit Purchase Option.
      In case
      of any consolidation of the Company with, or merger of the Company with, or
      merger of the Company into, another corporation (other than a consolidation
      or
      merger which does not result in any reclassification or change of the
      outstanding common stock), the corporation formed by such consolidation or
      merger shall execute and deliver to the Holder a supplemental Representatives'
      Unit Purchase Option providing that the holder of each Representatives' Unit
      Purchase Option then outstanding or to be outstanding shall have the right
      thereafter (until the stated expiration of such Representatives' Unit Purchase
      Option) to receive, upon exercise of such Representatives' Unit Purchase Option,
      the kind and amount of shares of stock and other securities and property
      receivable upon such consolidation or merger, by a holder of the number of
      common stock of the Company for which such Representatives' Unit Purchase Option
      might have been exercised immediately prior to such consolidation, merger,
      sale
      or transfer. Such supplemental Representatives' Unit Purchase Option shall
      provide for adjustments which shall be identical to the adjustments provided
      in
      Section 6. The above provision of this Section shall similarly apply to
      successive consolidations or mergers. 

    

    c)
      Fractional
      Interests.
      The
      Company shall not be required to issue certificates representing fractions
      of
      Common Stock, Class B Common Stock or Warrants upon the exercise of the
      Representatives' Unit Purchase Option, nor shall it be required to issue scrip
      or pay cash in lieu of any fractional interests, it being the intent of the
      parties that all fractional interests shall be eliminated by rounding any
      fraction up to the nearest whole number of Warrants, Common Stock, Class B
      Common Stock or other securities, properties or rights. 

    

    
      	
              7)

            	
              RESERVATION
                AND LISTING

            

    

    

    a)
      The
      Company shall at all times reserve and keep available out of its authorized
      Common Stock and Class B Common Stock, solely for the purpose of issuance upon
      exercise of the Representatives' Unit Purchase Options or the Warrants
      underlying the Representatives' Unit Purchase Option, such number of shares
      of
      Common Stock, Class B Common Stock or other securities, properties or rights
      as
      shall be issuable upon the exercise thereof. The Company covenants and agrees
      that, upon exercise of the Representatives' Unit Purchase Options and payment
      of
      the Exercise Price therefor, all Common Stock, Class B Common Stock and other
      securities issuable upon such exercise shall be duly and validly issued, fully
      paid and non-assessable and not subject to preemptive rights of any stockholder.
      The Company further covenants and agrees that upon exercise of the Warrants
      underlying the Representatives' Unit Purchase Options and payment of the
      respective Warrant exercise price therefor, all Common Stock and other
      securities issuable upon such exercise shall be duly and validly issued, fully
      paid and non-assessable and not subject to preemptive rights of any stockholder.
      

    

    b)
      As
      long
      as the Representatives' Unit Purchase Options shall be outstanding, the Company
      shall use its best efforts to cause all (i) Units, Common Stock and Class B
      Common Stock issuable upon exercise of the Representatives' Unit Purchase
      Options; (ii) Warrants issuable upon exercise of the Representatives' Unit
      Purchase Options; and (iii) Common Stock issuable upon exercise of the Warrants
      included in the Units issuable upon exercise of the Representatives' Unit
      Purchase Option to be listed (subject to official notice of issuance) on all
      securities exchanges (or, if applicable on the Nasdaq National Market, SmallCap
      Market, OTC Bulletin Board or any successor trading market) on which the Units,
      the Common Stock, Class B Common Stock or the Public Warrants issued to the
      public in connection herewith may then be listed and/or quoted. 

    

    
      	
              8)

            	
              CERTAIN
                NOTICE REQUIREMENTS

            

    

    

    a)
      Right
      to Notice.
      Nothing
      herein shall be construed as conferring upon the Holders the right to vote
      or
      consent as a stockholder for the election of directors or any other matter,
      or
      as having any rights whatsoever as a stockholder of the Company. If, however,
      at
      any time prior to the expiration of the Representatives' Unit Purchase Options
      and their exercise, any of the events described in Section 8(b) shall occur,
      then, in one or more of said events, the Company shall give written notice
      of
      such event at least fifteen days prior to the date fixed as a record date or
      the
      date of closing the transfer books for the determination of the stockholders
      entitled to such dividend, distribution, conversion or exchange of securities
      or
      subscription rights, or entitled to vote on such proposed dissolution,
      liquidation, winding up or sale. Such notice shall specify such record date
      or
      the date of the closing of the transfer books, as the case may be.
      Notwithstanding the foregoing, the Company shall deliver to each Holder a copy
      of each notice given to the other stockholders of the Company at the same time
      and in the same manner that such notice is given to the stockholders.

    

    
      
        
        

      

      
        Page
          8 of 12

        
          

        

      

      
        
        

      

    

    b)
      Enumerated
      Events.
      The
      Company shall be required to give the notice described in this Section 8 upon
      one or more of the following events: (i) if the Company shall take a record
      of
      the holders of its common stock for the purpose of entitling them to receive
      a
      dividend or distribution payable otherwise than in cash, or a cash dividend
      or
      distribution payable otherwise than out of retained earnings, as indicated
      by
      the accounting treatment of such dividend or distribution on the books of the
      Company; or (ii) the Company shall offer to all the holders of its common stock
      any additional shares of capital stock of the Company or securities convertible
      into or exchangeable for shares of capital stock of the Company, or any option,
      right or warrant to subscribe therefor; or (iii) a dissolution, liquidation
      or
      winding up of the Company (other than in connection with a consolidation or
      merger) or a sale of all or substantially all of its property, assets and
      business shall be proposed. 

    

    c)
      Change
      in Exercise Price.
      The
      Company shall, promptly after an event requiring a change in the Exercise Price
      pursuant to Section 6 hereof, send notice to the Holders of such event and
      change (the “Price Notice”). The Price Notice shall describe the event causing
      the change and the method of calculating same and shall be certified as being
      true and accurate by the Company’s President and Chief Financial
      Officer.

    

    d)
      Notice
      Delivery.
      All
      notices, requests, consents and other communications under this Representatives'
      Unit Purchase Option shall be in writing and shall be deemed to have been duly
      made when hand delivered, or sent via confirmed facsimile transmission, email
      or
      receipted overnight courier (: (i) If to the registered Holder of the
      Representatives' Unit Purchase Option, to the address of such Holder as shown
      on
      the books of the Company; or (ii) If to the Company, to the following address
      or
      to such other address as the Company may designate by notice to the Holders:
      

    

    Middle
      Kingdom Alliance Corp.

    333
      Sandy
      Springs Circle, Suite 223

    Atlanta,
      GA 30328

    Attn:
      David Rapaport, Secretary and General Counsel

    Fax:
      404-257-9125

    Email:
      drapaport@highcapus.com

    

    
      	
              9)

            	
              MISCELLANEOUS

            

    

    

      a)
        Amendments.
        The
        Company and I-Bankers may from time to time supplement or amend this
        Representatives' Unit Purchase Option without the approval of any of the
        Holders
        in order to cure any ambiguity, to correct or supplement any provision contained
        herein that may be defective or inconsistent with any other provisions herein,
        or to make any other provisions in regard to matters or questions arising
        hereunder that the Company and I-Bankers may deem necessary or desirable
        and that the Company and I-Bankers deem shall not adversely affect the
        interest of the Holders. All other modifications or amendments shall require
        the
        written consent of and be signed by the party against whom enforcement of
        the
        modification or amendment is sought. 

    

    b)
      Headings.
      The
      headings contained herein are for the sole purpose of convenience of reference,
      and shall not in any way limit or affect the meaning or interpretation of any
      of
      the terms or provisions of this Representatives' Unit Purchase Option.

    

    c)
      Entire
      Agreement.
      This
      Representatives' Unit Purchase Option (together with the other agreements and
      documents being delivered pursuant to or in connection with this
      Representatives' Unit Purchase Option) constitutes the entire agreement of
      the
      parties hereto with respect to the subject matter hereof, and supersedes all
      prior agreements and understandings of the parties, oral and written, with
      respect to the subject matter hereof. 

    

    d)
      Binding
      Effect.
      This
      Representatives' Unit Purchase Option shall inure solely to the benefit of,
      and
      shall be binding upon, the Holder and the Company and their permitted assignees,
      respective successors, legal representative and assigns, and no other person
      shall have or be construed to have any legal or equitable right, remedy or
      claim
      under or in respect of or by virtue of this Representatives' Unit Purchase
      Option or any provisions herein contained.

    

    
      
        
        

      

      
        Page
          9 of 12

        
          

        

      

      
        
        

      

    

    e)
      Governing
      Law.
      This
      Representatives' Unit Purchase Option shall be governed by and construed and
      enforced in accordance with the laws of the State of Florida, without giving
      effect to conflict of laws. The Company hereby agrees that any action,
      proceeding or claim against it arising out of, relating in any way to this
      Agreement shall be brought and enforced in the courts of the State of Florida
      of
      the United States of America for the Southern District of Florida, and
      irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive.
      The Company hereby waives any objection to such exclusive jurisdiction and
      that
      such courts represent an inconvenient forum. Any such process or summons to
      be
      served upon the Company may be served by transmitting a copy thereof by
      registered or certified mail, return receipt requested, postage prepaid,
      addressed to it at the address set forth in Section 8(d) hereof. Such mailing
      shall be deemed personal service and shall be legal and binding upon the Company
      in any action, proceeding or claim. The Company agrees that the prevailing
      party(ies) in any such action shall be entitled to recover from the other
      party(ies) all of its reasonable attorneys’ fees and expenses relating to such
      action or proceeding and/or incurred in connection with the preparation
      therefor.

    

    f)
      Waivers.
      The
      failure of the Company or the Holder to at any time enforce any of the
      provisions of this Representatives' Unit Purchase Option shall not be deemed
      or
      construed to be a waiver of any such provision, nor to in any way affect the
      validity of this Representatives' Unit Purchase Option or any provision hereof
      or the right of the Company or any Holder to thereafter enforce each and every
      provision of this Representatives' Unit Purchase Option. No waiver of any
      breach, non-compliance or non-fulfillment of any of the provisions of this
      Representatives' Unit Purchase Option shall be effective unless set forth in
      a
      written instrument executed by the party or parties against whom or which
      enforcement of such waiver is sought; and no waiver of any such breach,
      non-compliance or non-fulfillment shall be construed or deemed to be a waiver
      of
      any other or subsequent breach, non-compliance or non-fulfillment. 

    

    g)
      Counterparts.
      This
      Representatives' Unit Purchase Option may be executed in one or more
      counterparts, and by the different parties hereto in separate counterparts,
      each
      of which shall be deemed to be an original, but all of which taken together
      shall constitute one and the same agreement, and shall become effective when
      one
      or more counterparts has been signed by each of the parties hereto and delivered
      to each of the other parties hereto. 

    

      h)
        Exchange
        Agreement.
        As a
        condition of the Holder’s receipt and acceptance of this Representatives' Unit
        Purchase Option, Holder agrees that, at any time prior to the complete exercise
        of this Representatives' Unit Purchase Option by Holder, if the Company
        and I-Bankers enter into an agreement (the “Exchange Agreement”) pursuant
        to which they agree that all outstanding Representatives' Unit Purchase Options
        will be exchanged for securities or cash or a combination of both, then Holder
        shall agree to such exchange and become a party to the Exchange
        Agreement.

    

    IN
      WITNESS WHEREOF, the Company has caused this Representatives' Unit Purchase
      Option to be signed by its duly authorized officer this __________day of
      __________________ 2006. 

    

    

    

    
      	 	
              MIDDLE
                KINGDOM ALLIANCE CORP.

              

              

              By:
                ________________________________

              Print
                Name: _________________________

              Title:
                _______________________________

            

    

    

    

    
      
        
        

      

      
        Page
          10 of
          12

        
          

        

      

      
        
        

      

    

    Form
      To Be Used To Exercise Representatives' Unit Purchase
      Option

    

    
      	TO:	
              Middle
                Kingdom Alliance Corp.

            

    

    333
      Sandy
      Springs Circle, Suite 223

    Atlanta,
      GA 30328

    Attn:
      David Rapaport, Secretary and General Counsel)

    

    Date:
      __________________, 20___

    

    The
      undersigned hereby elects irrevocably to exercise all or a portion of the within
      Representatives' Unit Purchase Option and to purchase ____________ Series A
      Units and/or _________ Series B Units of Middle Kingdom Alliance Corp. and
      hereby makes payment of $_____________(at the rate of $__________per Unit)
      in
      payment of the Exercise Price pursuant thereto. Please issue the Common Stock
      and Warrants as to which this Representatives' Unit Purchase Option is exercised
      in accordance with the instructions given below. 

    or
      

    The
      undersigned hereby elects irrevocably to convert its right to purchase
      ____________ Series A Units and/or _________ Series B Units purchasable under
      the within Representatives' Unit Purchase Option by surrender of the unexercised
      portion of the attached Representatives' Unit Purchase Option (with a “Value”
based of $________based on a “Market Price” of $___________). Please issue the
      securities comprising the Units as to which this Representatives' Unit Purchase
      Option is exercised in accordance with the instructions given below.

    

    ____________________________________

    [Authorized
      Signature]

    

    ____________________________________

    [Print
      Name]

    

    ____________________________________

    [Signature
      Guaranteed]

    

    INSTRUCTIONS
      FOR REGISTRATION OF SECURITIES

    

    Name:
       _________________________________________________

    [Print
      in
      Block Letters]

    

    Address: _________________________________________________

    _________________________________________________

    

    NOTICE:
      THE SIGNATURE TO THIS FORM MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE
      FACE OF THE WITHIN REPRESENTATIVES' UNIT PURCHASE OPTION IN EVERY PARTICULAR
      WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATSOEVER, AND MUST BE
      GUARANTEED BY A BANK, OTHER THAN A SAVINGS BANK, OR BY A TRUST COMPANY OR BY
      A
      FIRM HAVING MEMBERSHIP ON A REGISTERED NATIONAL SECURITIES
      EXCHANGE.

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    Form
      To Be Used To Assign Representatives' Unit Purchase
      Option

    

    ASSIGNMENT

    

    (To
      be
      executed by the registered Holder to effect a transfer of the within
      Representatives' Unit Purchase Option) 

    

    FOR
      VALUE
      RECEIVED, _________________________ does hereby sell, assign and transfer unto
      _____________________the right to purchase___________ Series A Units and/or
      _____________ Series B Units of Middle Kingdom Alliance Corp. (the “Company”)
      evidenced by the within Representatives' Unit Purchase Option and does hereby
      authorize the Company to transfer such right on the books of the Company.

    

    Date:
      ________________________, 20___

    

    

    ____________________________________

    [Authorized
      Signature]

    

    

    ____________________________________

    [Print
      Name]

    

    

    ____________________________________

    [Signature
      Guaranteed]

    

    NOTICE:
      THE SIGNATURE TO THIS FORM MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE
      FACE OF THE WITHIN REPRESENTATIVES' UNIT PURCHASE OPTION IN EVERY PARTICULAR
      WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATSOEVER, AND MUST BE
      GUARANTEED BY A BANK, OTHER THAN A SAVINGS BANK, OR BY A TRUST COMPANY OR BY
      A
      FIRM HAVING MEMBERSHIP ON A REGISTERED NATIONAL SECURITIES EXCHANGE.Unassociated Document

    Exhibit
      4.8

     

    CLASS
      A WARRANT AGREEMENT

     

    Agreement
      made as of [____], 2006 between Middle Kingdom Alliance Corp., a corporation
      organized under the laws of Delaware, with offices at 333 Sandy Springs Circle,
      Suite 223, Atlanta, GA 30328 (“Company”), and Continental Stock
      Transfer & Trust Company, a New York corporation, with offices at
      Continental Stock Transfer & Trust Company, 17 Battery Place, 8th
      floor, New York NY, 10004 (“Warrant Agent”).

     

    

        WHEREAS,
          the Company is engaged in a public offering (“Public Offering”) of Series A
          Units and Series B Units (collectively, the “Units”) and, in connection
          therewith, has determined to issue and deliver up to (i) 900,000 Class A
          Warrants (plus an additional 135,000 Class A Warrants if the representative
          of
          the underwriters exercise their over-allotment option) to the public investors
          plus 452,250 Class A Warrants in connection with a private placement of
          securities to certain investors prior to the Public Offering (collectively,
          the
“Class A Warrants”), and (ii) 90,000 Class A Warrants to I-Bankers
          Securities, Inc. (the “Representative”) or their designees (“Representative’s
          Warrants” and, together with the Class A Warrants, the “Warrants”), each of such
          Warrants evidencing the right of the holder thereof to purchase one share,
          par
          value $0.001, of the Company’s common stock (“Common Stock”) for $5.00, subject
          to adjustment as described herein; and

    

     

    WHEREAS,
      the
      Company has filed with the Securities and Exchange Commission a Registration
      Statement, No. 333-133475 on Form S-1 (the “Registration Statement”)
      for the registration, under the Securities Act of 1933, as amended (“Act”) of,
      among other securities, the Warrants and the Common Stock issuable upon exercise
      of the Warrants; and

     

    WHEREAS,
      the
      Company desires the Warrant Agent to act on behalf of the Company, and the
      Warrant Agent is willing to so act, in connection with the issuance,
      registration, transfer, exchange and exercise of the Warrants; and

     

    WHEREAS,
      the
      Company desires to provide for the form and provisions of the Warrants, the
      terms upon which they shall be issued and exercised, and the respective rights,
      limitation of rights, and immunities of the Company, the Warrant Agent, and
      the
      holders of the Warrants; and

     

    WHEREAS,
      all
      acts and things have been done and performed which are necessary to make the
      Warrants, when executed on behalf of the Company and countersigned by or on
      behalf of the Warrant Agent, as provided herein, the valid, binding and legal
      obligations of the Company, and to authorize the execution and delivery of
      this
      Agreement.

     

    NOW,
      THEREFORE,
      in
      consideration of the mutual agreements herein contained, the parties hereto
      agree as follows:

     

    1.  Appointment
      of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent
      for the Company for the Warrants, and the Warrant Agent hereby accepts such
      appointment and agrees to perform the same in accordance with the terms and
      conditions set forth in this Agreement.

     

    2.  Warrants.

     

    2.1  Form
      of
      Warrant. Each Warrant shall be issued in registered form only, shall be in
      substantially the form of Exhibit
      A
      hereto,
      the provisions of which are incorporated herein and shall be signed by, or
      bear
      the facsimile signature of, the Chief Executive Officer, Chairman of the Board
      or President and Secretary of the Company and shall bear a facsimile of the
      Company’s seal. In the event the person whose facsimile signature has been
      placed upon any Warrant shall have ceased to serve in the capacity in which
      such
      person signed the Warrant before such Warrant is issued, it may be issued with
      the same effect as if he or she had not ceased to be such at the date of
      issuance.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    2.2  Effect
      of
      Countersignature. Unless and until countersigned by the Warrant Agent pursuant
      to this Agreement, a Warrant shall be invalid and of no effect and may not
      be
      exercised by the holder thereof.

     

    2.3  Registration.

     

    2.3.1  Warrant
      Register. The Warrant Agent shall maintain books (“Warrant Register”), for the
      registration of original issuance and the registration of transfer of the
      Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall
      issue and register the Warrants in the names of the respective holders thereof
      in such denominations and otherwise in accordance with instructions delivered
      to
      the Warrant Agent by the Company.

     

    2.3.2  Registered
      Holder. Prior to due presentment for registration of transfer of any Warrant,
      the Company and the Warrant Agent may deem and treat the person in whose name
      such Warrant shall be registered upon the Warrant Register (“registered
      holder”), as the absolute owner of such Warrant and of each Warrant represented
      thereby (notwithstanding any notation of ownership or other writing on the
      Warrant Certificate made by anyone other than the Company or the Warrant Agent),
      for the purpose of any exercise thereof, and for all other purposes, and neither
      the Company nor the Warrant Agent shall be affected by any notice to the
      contrary.

     

    2.4  Detachability
      of Warrants. The securities comprising the Units will not be separately
      transferable until 90 days after the date hereof unless the Representative
      informs the Company of its decision to allow earlier separate trading, but
      in no
      event will the Representative allow separate trading of the securities
      comprising the Units until the Company files a Report on Form 8-K which
      includes an audited balance sheet reflecting the receipt by the Company of
      the
      gross proceeds of the Public Offering including the proceeds received by the
      Company from the exercise of the Underwriter’s over-allotment option, if the
      over-allotment option is exercised prior to the filing of the
      Form 8-K.

     

    2.5  Warrants
      and Representative’s Warrants. The Representative’s Warrants shall have the same
      terms and be in the same form as the Class A Warrants.

     

    3.  Terms
      and
      Exercise of Warrants

     

    3.1  Warrant
      Price. Each Class A Warrant and each Representative’s Warrant shall, when
      countersigned by the Warrant Agent, entitle the registered holder thereof,
      subject to the provisions of such Class A Warrant or Representative’s Warrant
      and of this Warrant Agreement, to purchase from the Company the number of Common
      Stock stated therein, at the price of $5.00
      per
      whole
      share, subject to the adjustments provided in Section 4 hereof and in the
      last sentence of this Section 3.1. The term “Warrant Price” as used in this
      Warrant Agreement refers to the price per share at which Common Stock may be
      purchased at the time a Warrant is exercised. The Company in its sole discretion
      may lower the Warrant Price at any time prior to the Expiration
      Date.

     

      3.2  Duration
        of Warrants. A Warrant may be exercised only during the period (“Exercise
        Period”) commencing on the later of the consummation by the Company of a merger,
        capital stock exchange, asset acquisition or other similar business combination
        (“Business Combination”) (as described more fully in the Company’s Registration
        Statement) or [__], 2007, and terminating at 5:00 p.m., New York City time
        on
        [__], 2013 (“Expiration Date”). Each Warrant not exercised on or before the
        Expiration Date shall become void, and all rights thereunder and all rights
        in
        respect thereof under this Agreement shall cease at the close of business
        on the
        Expiration Date. The Company in its sole discretion may extend the duration
        of
        the Warrants by delaying the Expiration Date. Notwithstanding
        the foregoing, a Warrant may expire unexercised regardless of whether a
        registration statement is currently effective under the Act with respect
        to the
        Common Stock issuable upon exercise of the Warrants.

     

    3.3  Exercise
      of Warrants.

     

    3.3.1  Payment.
      Subject to the provisions of the Warrant and this Warrant Agreement, a Warrant,
      when countersigned by the Warrant Agent, may be exercised by the registered
      holder thereof by surrendering it, at the office of the Warrant Agent, or at
      the
      office of its successor as Warrant Agent, in the Borough of Manhattan, City
      and
      State of New York, with the subscription form, as set forth in the Warrant,
      duly
      executed, and (i) by paying in full, in lawful money of the United States,
      in cash, good certified check or good bank draft payable to the order of the
      Company (or as otherwise agreed to by the Company), the Warrant Price for each
      full share of Common Stock as to which the Warrant is exercised and any and
      all
      applicable taxes due in connection with the exercise of the Warrant, the
      exchange of the Warrant for the Common Stock, and the issuance of the Common
      Stock or (ii) in the event that the Board of Directors of the Company, in
      their sole discretion, determine that the Warrants may be exercised on a
“cashless basis”, by surrendering his or her Warrant for that number of shares
      of Common Stock equal to the quotient obtained by dividing (x) the product
      of the number of shares of Common Stock underlying the Warrant, multiplied
      by
      the difference between the Warrant Price and the “Fair Market Value” (defined
      below) by (y) the Fair Market Value. The “Fair Market Value” shall mean
      the date of exercise of the Warrant.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    3.3.2  Issuance
      of Certificates. As soon as practicable after the exercise of any Warrant and
      the clearance of the funds in payment of the Warrant Price, the Company shall
      issue to the registered holder of such Warrant a certificate or certificates
      for
      the number of full shares of Common Stock to which he is entitled, registered
      in
      such name or names as may be directed by him, her or it, and if such Warrant
      shall not have been exercised in full, a new countersigned Warrant for the
      number of shares as to which such Warrant shall not have been exercised.
      Notwithstanding the foregoing, the Company shall not be obligated to deliver
      any
      securities pursuant to the exercise of a Warrant unless a registration statement
      under the Act with respect to the Common Stock is effective. Warrants may not
      be
      exercised by, or securities issued to, any registered holder in any state in
      which such exercise would be unlawful.

     

    3.3.3  Valid
      Issuance. All Common Stock issued upon the proper exercise of a Warrant in
      conformity with this Agreement shall be validly issued, fully paid and
      nonassessable.

     

    3.3.4  Date
      of
      Issuance. Each person in whose name any such certificate for Common Stock is
      issued shall for all purposes be deemed to have become the holder of record
      of
      such shares on the date on which the Warrant was surrendered and payment of
      the
      Warrant Price was made, irrespective of the date of delivery of such
      certificate, except that, if the date of such surrender and payment is a date
      when the stock transfer books of the Company are closed, such person shall
      be
      deemed to have become the holder of such shares at the close of business on
      the
      next succeeding date on which the stock transfer books are open.

     

    3.3.5  Warrant
      Solicitation and Warrant Solicitation Fee.

     

      (a)  The
        Company has engaged the Representative, on a non-exclusive basis, as its
        agent
        for the solicitation of the exercise of the Warrants. The Company, at its
        cost,
        will (i) assist the Representative with respect to such solicitation, if
        requested by the Representative, and (ii) provide the Representative, and
        direct the Company’s transfer agent and the Warrant Agent to deliver to the
        Representative, lists of the record and, to the extent known, beneficial
        owners
        of the Warrants. The Company hereby instructs the Warrant Agent to cooperate
        with the Representative in every respect in connection with the Representative's
        solicitation activities, including, but not limited to, providing to the
        Representative, at the Company’s cost, a list of record holders of the Warrants
        and circulating a prospectus or offering circular disclosing the compensation
        arrangements referenced in Section 3.3.5(b) below to holders of the
        Warrants at the time of exercise of the Warrants. In addition to the conditions
        set forth in Section 3.3.5(b), the Representative shall accept payment of
        the warrant solicitation fee provided in Section 3.3.5(b) only if they have
        provided bona fide services to the Company in connection with the exercise
        of
        the Warrants and only to the extent that an investor who exercises his Warrants
        specifically designates, in writing, that the Representative solicited his
        exercise. In addition to soliciting, either orally or in writing, the exercise
        of Warrants by a Warrant holder, such services may also include disseminating
        information, either orally or in writing, to Warrant holders about the Company
        or the market for the Company’s securities, or assisting in the processing of
        the exercise of Warrants.

     

      (b)  In
        each
        instance in which a Warrant is exercised, the Warrant Agent shall promptly
        give
        written notice of such exercise to the Company and the Representative (“Warrant
        Agent’s Exercise Notice”). If, upon the exercise of any Warrant more than one
        year from the effective date of the Registration Statement, (i) the market
        price of the Company’s Common Stock is greater than the Warrant Price,
        (ii) disclosure of compensation arrangements between the Company and the
        Representative with respect to the solicitation of the exercise of the Warrants
        was made both at the time of the Public Offering and at the time of exercise
        (by
        delivery of the Prospectus or as otherwise required by applicable law, rule
        or
        regulation), (iii) the holder of the Warrant confirms in writing that the
        exercise of the Warrant was solicited by the Representative, (iv) the
        Warrant was not held in a discretionary account, and (v) the solicitation
        of the exercise of the Warrant was not in violation of Regulation M (as
        such rule or any successor rule may be in effect as of such time of exercise)
        promulgated under the Securities Exchange Act of 1934, as amended, then the
        Warrant Agent, simultaneously with the distribution of the Common Stock
        underlying the Warrants so exercised in accordance with the instructions
        from
        the Company following receipt of the proceeds to the Company received upon
        exercise of such Warrant(s), shall, on behalf of the Company, pay a fee of
        5% of
        the Warrant Price to the Representative, provided that the Representative
        deliver to the Warrant Agent within ten (10) business days from the date on
        which the Representative has received the Warrant Agent’s Exercise Notice, a
        certificate that the conditions set forth the preceding clauses (ii),
        (iii), (iv) and (v) have been satisfied. Notwithstanding the foregoing, no
        fee
        will be paid to the Representative with respect to the exercise by the
        Underwriters or their affiliates or the Company’s officers or directors of
        Warrants purchased by them upon exercise of the Representative’s Warrants and
        still held by any of the foregoing for their own account. The Representative
        and
        the Company may at any time during business hours, examine the records of
        the
        Warrant Agent, including its ledger of original Warrant certificates returned
        to
        the Warrant Agent upon exercise of Warrants.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

      (c)  The
        provisions of this Section 3.3.5. may not be modified, amended or deleted
        without the prior written consent of the Representative.

     

    4.  Adjustments.

     

    4.1  Stock
      Dividends - Split-Ups. If after the date hereof, and subject to the provisions
      of Section 4.6 below, the number of outstanding shares of Common Stock is
      increased by a stock dividend payable in Common Stock, or by a split-up of
      Common Stock, or other similar event, then, on the effective date of such stock
      dividend, split-up or similar event, the number of shares of Common Stock
      issuable on exercise of each Warrant shall be increased in proportion to such
      increase in outstanding Common Stock.

     

    4.2  Aggregation
      of Shares. If after the date hereof, and subject to the provisions of
      Section 4.6, the number of outstanding shares of Common Stock is decreased
      by a consolidation, combination, reverse stock split or reclassification of
      Common Stock or other similar event, then, on the effective date of such
      consolidation, combination, reverse stock split, reclassification or similar
      event, the number of shares of Common Stock issuable on exercise of each Warrant
      shall be decreased in proportion to such decrease in outstanding shares of
      Common Stock.

     

    4.3  Adjustments
      in Exercise Price. Whenever the number of shares of Common Stock purchasable
      upon the exercise of the Warrants is adjusted, as provided in Section 4.1
      and 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by
      multiplying such Warrant Price immediately prior to such adjustment by a
      fraction (x) the numerator of which shall be the number of shares of Common
      Stock purchasable upon the exercise of the Warrants immediately prior to such
      adjustment, and (y) the denominator of which shall be the number of shares
      of Common Stock so purchasable immediately thereafter.

     

    4.4  Replacement
      of Securities upon Reorganization, etc. In case of any reclassification or
      reorganization of the outstanding Common Stock (other than a change covered
      by
      Section 4.1 or 4.2 hereof or that solely affects the par value of such
      Common Stock), or in the case of any consolidation of the Company with or into
      another corporation (other than a consolidation or merger in which the Company
      is the continuing corporation and that does not result in any reclassification
      or reorganization of the outstanding Common Stock), or in the case of any merger
      or sale or conveyance to another corporation or entity of the assets or other
      property of the Company as an entirety or substantially as an entirety in
      connection with which the Company is dissolved, the Warrant holders shall
      thereafter have the right to purchase and receive, upon the basis and upon
      the
      terms and conditions specified in the Warrants and in lieu of the Common Stock
      of the Company immediately theretofore purchasable and receivable upon the
      exercise of the rights represented thereby, the kind and amount of shares of
      stock or other securities or property (including cash) receivable upon such
      reclassification, reorganization, merger or consolidation, or upon a dissolution
      following any such sale or transfer, that the Warrant holder would have received
      if such Warrant holder had exercised his, her or its Warrant(s) immediately
      prior to such event; and if any reclassification also results in a change in
      Common Stock covered by Section 4.1 or 4.2, then such adjustment shall be
      made pursuant to Sections 4.1, 4.2, 4.3 and this Section 4.4. The
      provisions of this Section 4.4 shall similarly apply to successive
      reclassifications, reorganizations, mergers or consolidations, sales or other
      transfers.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    4.5  Notices
      of Changes in Warrant. Upon every adjustment of the Warrant Price or the number
      of shares issuable upon exercise of a Warrant, the Company shall give written
      notice thereof to the Warrant Agent, which notice shall state the Warrant Price
      resulting from such adjustment and the increase or decrease, if any, in the
      number of shares purchasable at such price upon the exercise of a Warrant,
      setting forth in reasonable detail the method of calculation and the facts
      upon
      which such calculation is based. Upon the occurrence of any event specified
      in
      Sections 4.1, 4.2, 4.3 or 4.4, then, in any such event, the Company shall
      give written notice to the Warrant holder, at the last address set forth for
      such holder in the warrant register, of the record date or the effective date
      of
      the event. Failure to give such notice, or any defect therein, shall not affect
      the legality or validity of such event.

     

    4.6  No
      Fractional Shares. Notwithstanding any provision contained in this Warrant
      Agreement to the contrary, the Company shall not issue fractional shares upon
      exercise of Warrants. If, by reason of any adjustment made pursuant to this
      Section 4, the holder of any Warrant would be entitled, upon the exercise
      of such Warrant, to receive a fractional interest in a share, the Company shall,
      upon such exercise, round up to the nearest whole number the number of the
      Common Stock to be issued to the Warrant holder.

     

    4.7  Form
      of
      Warrant. The form of Warrant need not be changed because of any adjustment
      pursuant to this Section 4, and Warrants issued after such adjustment may
      state the same Warrant Price and the same number of shares as is stated in
      the
      Warrants initially issued pursuant to this Agreement. However, the Company
      may
      at any time in its sole discretion make any change in the form of Warrant that
      the Company may deem appropriate and that does not affect the substance thereof,
      and any Warrant thereafter issued or countersigned, whether in exchange or
      substitution for an outstanding Warrant or otherwise, may be in the form as
      so
      changed.

     

    5.  Transfer
      and Exchange of Warrants.

     

    5.1  Registration
      of Transfer. The Warrant Agent shall register the transfer, from time to time,
      of any outstanding Warrant upon the Warrant Register, upon surrender of such
      Warrant for transfer, properly endorsed with signatures properly guaranteed
      and
      accompanied by appropriate instructions for transfer. Upon any such transfer,
      a
      new Warrant representing an equal aggregate number of Warrants shall be issued
      and the old Warrant shall be cancelled by the Warrant Agent. The Warrants so
      cancelled shall be delivered by the Warrant Agent to the Company from time
      to
      time upon request.

     

    5.2  Procedure
      for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent,
      together with a written request for exchange or transfer, and thereupon the
      Warrant Agent shall issue in exchange therefor one or more new Warrants as
      requested by the registered holder of the Warrants so surrendered, representing
      an equal aggregate number of Warrants; provided, however, that in the event
      that
      a Warrant surrendered for transfer bears a restrictive legend, the Warrant
      Agent
      shall not cancel such Warrant and issue new Warrants in exchange therefor until
      the Warrant Agent has received an opinion of counsel acceptable to the Company
      stating that such transfer may be made and indicating whether the new Warrants
      must also bear a restrictive legend.

     

    5.3  Fractional
      Warrants. The Warrant Agent shall not be required to effect any registration
      of
      transfer or exchange which will result in the issuance of a warrant certificate
      for a fraction of a warrant.

     

    5.4  Service
      Charges. No service charge shall be made for any exchange or registration of
      transfer of Warrants.

     

    Warrant
      Execution and Countersignature. The Warrant Agent is hereby authorized to
      countersign and to deliver, in accordance with the terms of this Agreement,
      the
      Warrants required to be issued pursuant to the provisions of this
      Section 5, and the Company, whenever required by the Warrant Agent, will
      supply the Warrant Agent with Warrants duly executed on behalf of the Company
      for such purpose.

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    6.  Other
      Provisions Relating to Rights of Holders of Warrants.

     

    6.1  No
      Rights
      as Stockholder. A Warrant does not entitle the registered holder thereof to
      any
      of the rights of a stockholder of the Company, including, without limitation,
      the right to receive dividends, or other distributions, exercise any preemptive
      rights, to vote or to consent or to receive notice as stockholders in respect
      of
      the meetings of stockholders or the election of directors of the Company or
      any
      other matter.

     

    6.2  Lost,
      Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen,
      mutilated, or destroyed, the Company and the Warrant Agent may on such terms
      as
      to indemnity or otherwise as they may in their discretion impose (which shall,
      in the case of a mutilated Warrant, include the surrender thereof), issue a
      new
      Warrant of like denomination, tenor, and date as the Warrant so lost, stolen,
      mutilated, or destroyed. Any such new Warrant shall constitute a substitute
      contractual obligation of the Company, whether or not the allegedly lost,
      stolen, mutilated, or destroyed Warrant shall be at any time enforceable by
      anyone.

     

    6.3  Reservation
      of Common Stock. The Company shall at all times reserve and keep available
      a
      number of its authorized but unissued Common Stock that will be sufficient
      to
      permit the exercise in full of all outstanding Warrants issued pursuant to
      this
      Agreement.

     

    6.4  Registration
      of Common Stock. The Company agrees that prior to the commencement of the
      Exercise Period, it shall file with the Securities and Exchange Commission
      a
      post-effective amendment to the Registration Statement, or a new registration
      statement, for the registration, under the Act, of, and it shall take such
      action as is necessary to qualify for sale, in those states in which the
      Warrants were initially offered by the Company, the Common Stock issuable upon
      exercise of the Warrants. In either case, the Company will use its best efforts
      to cause the same to become effective and to maintain the effectiveness of
      such
      registration statement until the expiration of the Warrants in accordance with
      the provisions of this Agreement. In no event will the registered holder of
      a
      Warrant be entitled to receive a net-cash settlement in lieu of physical
      settlement in shares of Common Stock, regardless of whether the Common Stock
      underlying the Warrants is registered pursuant to an effective registration
      statement.

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

    7.  Concerning
      the Warrant Agent and Other Matters.

     

    7.1  Payment
      of Taxes. The Company will from time to time promptly pay all taxes and charges
      that may be imposed upon the Company or the Warrant Agent in respect of the
      issuance or delivery of Common Stock upon the exercise of Warrants, but the
      Company shall not be obligated to pay any transfer taxes in respect of the
      Warrants or such shares.

     

    7.2  Resignation,
      Consolidation or Merger of Warrant Agent.

     

    7.2.1  Appointment
      of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter
      appointed, may resign its duties and be discharged from all further duties
      and
      liabilities hereunder after giving sixty (60) days’ notice in writing to
      the Company. If the office of the Warrant Agent becomes vacant by resignation
      or
      incapacity to act or otherwise, the Company shall appoint in writing a successor
      Warrant Agent in place of the Warrant Agent. If the Company shall fail to make
      such appointment within a period of 30 days after it has been notified in
      writing of such resignation or incapacity by the Warrant Agent or by the holder
      of the Warrant (who shall, with such notice, submit his Warrant for inspection
      by the Company), then the holder of any Warrant may apply to the Supreme Court
      of the State of New York for the County of New York for the appointment of
      a
      successor Warrant Agent at the Company’s cost. Any successor Warrant Agent,
      whether appointed by the Company or by such court, shall be a corporation
      organized and existing under the laws of the State of New York, in good standing
      and having its principal office in the Borough of Manhattan, City and State
      of
      New York, and authorized under such laws to exercise corporate trust powers
      and
      subject to supervision or examination by federal or state authority. After
      appointment, any successor Warrant Agent shall be vested with all the authority,
      powers, rights, immunities, duties, and obligations of its predecessor Warrant
      Agent with like effect as if originally named as Warrant Agent hereunder,
      without any further act or deed; but if for any reason it becomes necessary
      or
      appropriate, the predecessor Warrant Agent shall execute and deliver, at the
      expense of the Company, an instrument transferring to such successor Warrant
      Agent all the authority, powers, and rights of such predecessor Warrant Agent
      hereunder; and upon request of any successor Warrant Agent the Company shall
      make, execute, acknowledge, and deliver any and all instruments in writing
      for
      more fully and effectually vesting in and confirming to such successor Warrant
      Agent all such authority, powers, rights, immunities, duties, and
      obligations.

     

    7.2.2  Notice
      of
      Successor Warrant Agent. In the event a successor Warrant Agent shall be
      appointed, the Company shall give notice thereof to the predecessor Warrant
      Agent and the transfer agent for the Common Stock not later than the effective
      date of any such appointment.

     

    7.2.3  Merger
      or
      Consolidation of Warrant Agent. Any corporation into which the Warrant Agent
      may
      be merged or with which it may be consolidated or any corporation resulting
      from
      any merger or consolidation to which the Warrant Agent shall be a party to
      and
      shall be the successor Warrant Agent under this Agreement without any further
      act.

     

    7.3  Fees
      and
      Expenses of Warrant Agent.

     

    7.3.1  Remuneration.
      The Company agrees to pay the Warrant Agent reasonable remuneration for its
      services as such Warrant Agent hereunder and will reimburse the Warrant Agent
      upon demand for all expenditures that the Warrant Agent may reasonably incur
      in
      the execution of its duties hereunder.

     

    7.3.2  Further
      Assurances. The Company agrees to perform, execute, acknowledge, and deliver
      or
      cause to be performed, executed, acknowledged, and delivered all such further
      and other acts, instruments, and assurances as may reasonably be required by
      the
      Warrant Agent for the carrying out or performing of the provisions of this
      Agreement.

     

    7.4  Liability
      of Warrant Agent.

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     

    7.4.1  Reliance
      on Company Statement. Whenever in the performance of its duties under this
      Warrant Agreement, the Warrant Agent shall deem it necessary or desirable that
      any fact or matter be proved or established by the Company prior to taking
      or
      suffering any action hereunder, such fact or matter (unless other evidence
      in
      respect thereof be herein specifically prescribed) may be deemed to be
      conclusively proved and established by a statement signed by the Chief Executive
      Officer, Chief Financial Officer, or Secretary of the Company and delivered
      to
      the Warrant Agent. The Warrant Agent may rely upon such statement for any action
      taken or suffered in good faith by it pursuant to the provisions of this
      Agreement.

     

    7.4.2  Indemnity.
      The Warrant Agent shall be liable hereunder only for its own negligence, willful
      misconduct or bad faith. The Company agrees to indemnify the Warrant Agent
      and
      save it harmless against any and all liabilities, including judgments, costs
      and
      reasonable counsel fees, for anything done or omitted by the Warrant Agent
      in
      the execution of this Agreement, except as a result of the Warrant Agent’s
      negligence, willful misconduct, or bad faith.

     

    7.4.3  Exclusions.
      The Warrant Agent shall have no responsibility with respect to the validity
      of
      this Agreement or with respect to the validity or execution of any Warrant
      (except its countersignature thereof); nor shall it be responsible for any
      breach by the Company of any covenant or condition contained in this Agreement
      or in any Warrant; nor shall it be responsible to make any adjustments required
      under the provisions of Section 4 hereof or responsible for the manner,
      method, or amount of any such adjustment or the ascertaining of the existence
      of
      facts that would require any such adjustment; nor shall it by any act hereunder
      be deemed to make any representation or warranty as to the authorization or
      reservation of any Common Stock to be issued pursuant to this Agreement or
      any
      Warrant or as to whether any Common Stock will when issued be valid and fully
      paid and nonassessable.

     

      7.5  Acceptance
        of Agency. The Warrant Agent hereby accepts the agency established by this
        Agreement and agrees to perform the same upon the terms and conditions herein
        set forth and among other things, shall account promptly to the Company with
        respect to Warrants exercised and concurrently account for, and pay to the
        Company, all moneys received by the Warrant Agent for the purchase of shares
        of
        the Company’s Common Stock (less any warrant solicitation fee due to the
        Representative pursuant to Section 3.3.5 herein) through the exercise of
        Warrants.

     

    8.  Miscellaneous
      Provisions.

     

    8.1  Successors.
      All the covenants and provisions of this Agreement by or for the benefit of
      the
      Company or the Warrant Agent shall bind and inure to the benefit of their
      respective successors and assigns.

     

    8.2  Notices.
      Any notice, statement or demand authorized by this Warrant Agreement to be
      given
      or made by the Warrant Agent or by the holder of any Warrant to or on the
      Company shall be sufficiently given when so delivered if by hand or overnight
      delivery or if sent by certified mail or private courier service within five
      days after deposit of such notice, postage prepaid, addressed (until another
      address is filed in writing by the Company with the Warrant Agent), as
      follows:

    

    Middle
      Kingdom Alliance Corp.

    333
      Sandy
      Springs Circle

    Suite
      223

    Atlanta,
      GA 30328

    Attn:
      David A. Rapaport, Secretary and General Counsel

     

    Any
      notice, statement or demand authorized by this Agreement to be given or made
      by
      the holder of any Warrant or by the Company to or on the Warrant Agent shall
      be
      sufficiently given when so delivered if by hand or overnight delivery or if
      sent
      by certified mail or private courier service within five days after deposit
      of
      such notice, postage prepaid, addressed (until another address is filed in
      writing by the Warrant Agent with the Company), as follows:

     

    Continental
      Stock Transfer & Trust Co

    17
      Battery Place, 8th floor

    New
      York
      NY 10004

    Tel:
      (212) 845-3201

    Fax: 
      (212) 509-5150

    Attn:
      Compliance Department

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

     

    with
      a
      copy in either case to:

     

    Cozen
      O’Connor

    The
      Army
& Navy Club Building

    1627
      I
      Street, NW, Suite 1100

    Washington,
      DC 20006

    Attn:
      Ralph V. De Martino, Esq.

    

    and

    

    I-Bankers
      Securities, Inc.

    

        3340
          Indian Creek Court

        Fort
          Worth, Texas 76180

    

    Attn:
      [__________]

     

    8.3  Applicable
      law. The validity, interpretation, and performance of this Agreement and of
      the
      Warrants shall be governed in all respects by the laws of the State of Delaware,
      without giving effect to conflict of laws. The Company hereby agrees that any
      action, proceeding or claim against it arising out of or relating in any way
      to
      this Agreement shall be brought and enforced in the courts of the State of
      Delaware or the United States District Court for Delaware, and irrevocably
      submits to such jurisdiction, which jurisdiction shall be exclusive. The Company
      hereby waives any objection to such exclusive jurisdiction and that such courts
      represent an inconvenient forum. Any such process or summons to be served upon
      the Company may be served by transmitting a copy thereof by registered or
      certified mail, return receipt requested, postage prepaid, addressed to it
      at
      the address set forth in Section 8.2 hereof. Such mailing shall be deemed
      personal service and shall be legal and binding upon the Company in any action,
      proceeding or claim.

     

      8.4  Persons
        Having Rights under this Agreement. Nothing in this Agreement expressed and
        nothing that may be implied from any of the provisions hereof is intended,
        or
        shall be construed, to confer upon, or give to, any person or corporation
        other
        than the parties hereto and the registered holders of the Warrants and, for
        the
        purposes of Sections 3.3.5, 6.4 and 8.2 hereof, the Representative, any
        right, remedy, or claim under or by reason of this Warrant Agreement or of
        any
        covenant, condition, stipulation, promise, or agreement hereof. The
        Representative shall be deemed to be a third-party beneficiary of this Agreement
        with respect to Sections 3.3.5, 6.4 and 8.2 hereof. All covenants,
        conditions, stipulations, promises, and agreements contained in this Warrant
        Agreement shall be for the sole and exclusive benefit of the parties hereto
        (and
        the Representative with respect to the Sections 3.3.5, 6.4 and 8.2 hereof)
        and their successors and assigns and of the registered holders of the
        Warrants.

     

    8.5  Examination
      of the Warrant Agreement. A copy of this Agreement shall be available at all
      reasonable times at the office of the Warrant Agent in the Borough of Manhattan,
      City and State of New York, for inspection by the registered holder of any
      Warrant. The Warrant Agent may require any such holder to submit his Warrant
      for
      inspection by it.

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

     

    8.6  Counterparts.
      This Agreement may be executed in any number of counterparts and each of such
      counterparts shall for all purposes be deemed to be an original, and all such
      counterparts shall together constitute but one and the same
      instrument.

     

    8.7  Effect
      of
      Headings. The Section headings herein are for convenience only and are not
      part
      of this Warrant Agreement and shall not affect the interpretation
      thereof.

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

     

    IN
      WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto
      as
      of the day and year first above written.

    
      	 	 	 
	 	MIDDLE
              KINGDOM
              ALLIANCE CORP. 
	 
 	 
 	 
 
	 	By:  	
            
	 	
              
Bernard
              J. Tanenbaum III, Chief Executive
              Officer

    

     

      
        	 	 	 
	 	
                CONTINENTAL
                  STOCK
                  TRANSFER &

                TRUST
                  COMPANY

              
	 
 	 
 	 
 
	 	By:  	 
	 	
                
Name: Steven
                Nelson
	 	Title: Chairman

     

    
      
        
        

      

      
        11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}]]